Rosmarinic acid
Rosmarinic acid is a naturally occurring phenolic compound widely found in plants of the Lamiaceae family, including Salvia species and chia (Salvia hispanica).
Rosmarinic acid is a naturally occurring phenolic compound widely found in plants of the Lamiaceae family, including Salvia species and chia (Salvia hispanica). Chemically, it is a caffeic acid ester with strong antioxidant properties, and it is frequently studied as a bioactive phytochemical rather than as a conventional drug. In biomedical research, rosmarinic acid is of interest because it can modulate oxidative stress, inflammatory signaling, and cell survival pathways, which has led to investigation in metabolic, neuroprotective, antimicrobial, and anticancer contexts.
Recent studies have continued to position rosmarinic acid as a multifunctional natural product with potential pharmaceutical relevance. Its reported activities include antioxidant effects, enzyme inhibition, and support for nanomedicine-based delivery systems. In the publications summarized here, rosmarinic acid was examined both as a major plant metabolite and as an active component incorporated into engineered nanoparticles, including PLGA nanoparticles, polydopamine-based nanotherapeutics, and RA-Se@M self-assembled systems. These studies collectively reflect its role as a bioactive scaffold in oxidative stress-related disease models, including Parkinson’s disease, pancreatic cancer, triple-negative breast cancer, and postprandial glucose modulation.
Where the papers sit
11 papers from the last 6 months study rosmarinic acid directly · updated from PubMed 15 Nov 2026
Study type 0 clinical trials · 1 human data · 10 preclinical
Themes 3 themes · 2 new directions
-
Phytochemical Profiling and Enzyme Inhibition
Solvent-sensitive phytochemical profiling is being paired with antioxidant and enzyme-inhibition assays, especially α-glucosidase testing. Rosmarinic acid quantification is also moving toward rapid voltammetric measurement in Origanum extracts. Across plant matrices, extract composition varies with solvent and species, complicating direct comparisons. The common aim is to connect phenolic composition with postprandial glucose control and antioxidant capacity.
4 papers · 36.4%
-
Inflammation and Tissue Protection
Anti-inflammatory signaling is the shared focus, with rosmarinic acid linked to NRF2/HO-1, NF-κB and NLRP3 modulation in toxic testicular injury. A separate asthma study implicates EGFR in relief of cough-variant symptoms. The work is moving toward pathway-targeted protection rather than nonspecific antioxidant claims. Whether these mechanisms translate across inflammatory diseases remains open.
2 papers · 18.2%
-
Others — Formulated Combination Therapies
Hydrogels, cubosomes, nanozymes and brain-targeted carriers are being used to improve delivery or combine rosmarinic acid with other treatments. Reported targets include diabetic wound angiogenesis, hyperthermia-induced apoptosis, melanoma, Parkinson’s disease and protein amyloidosis. Oxidative stress, hypoxia, survivin and cysteine-dependent apoptosis recur, but the therapeutic settings and mechanisms diverge. The cluster therefore reflects broad formulation-driven preclinical exploration rather than one convergent disease program.
5 papers · 45.5%
Rosmarinic acid is assigned a protein-aggregation-control role in insulin therapy
The insulin-complexation study in Drosophila melanogaster treats insulin amyloidosis as a formulation problem and finds that rosmarinic acid binds aggregation-prone regions of insulin, inhibits fibrillation dose-dependently, and improves the management of diabetic traits when combined with insulin 42331169Jun. This differs from the set’s other uses of rosmarinic acid as an antioxidant, anti-inflammatory, neuroprotective agent, or enzyme-inhibitory constituent: it makes rosmarinic acid a direct inhibitor of therapeutic-protein amyloid formation, opening a formulation-stabilization role rather than another application of cellular protection.
Rosmarinic acid acts as a heat-shock-response disarmer that sensitizes cancer cells to hyperthermia
The A549 non-small cell lung cancer cell model treated with mild hyperthermia assumed rosmarinic acid would function as a conventional direct cytotoxic or antioxidant adjunct, but found that it suppresses the canonical HSF1-mediated heat-shock response, increases oxidative stress, and potentiates hyperthermia-induced apoptosis. The result gives rosmarinic acid a distinct role as an inhibitor of cellular heat-stress adaptation. 42921998Oct
Papers
The 11 papers from the last 6 months that study rosmarinic acid directly, newest first, by theme and by study type. Study types come from PubMed publication types and MeSH headings.
By theme
Phytochemical Profiling and Enzyme Inhibition (4)
- A Novel Voltammetric Approach for the Rapid Quantification of Rosmarinic Acid in Origanum micranthum and Origanum minutiflorum. Chemistry & biodiversity · 1 Nov 2026 PMID 42967481
- Unlocking the Role of Chia (Salvia hispanica L.) Seed Phenolic Metabolites in Postprandial Glucose Modulation: in vitro, in vivo, and Antioxidant Evidence Supported by Molecular Docking. Plant foods for human nutrition (Dordrecht, Netherlands) · 18 Jun 2026 PMID 42313210
- Solvent-Dependent GC-MS and LC-MS/MS Phytochemical Profiling of Echium italicum L. Aerial Part Extracts and In Vitro Enzyme Inhibitory and DNA-Protective Effects. Biomedical chromatography : BMC · 11 Jun 2026 PMID 42274011
- Evaluation of the Phytochemical Composition, Antioxidant Activity, and Enzyme Inhibitory Potential of Salvia heldreichiana Within the Framework of Molecular Docking and CAVER Tunnel Analysis. ChemistryOpen · 1 Jun 2026 PMID 42220228
Inflammation and Tissue Protection (2)
- Nano-Rosmarinic Acid Protects Against Chlorfenapyr-Induced Testicular Toxicity Through Modulation of NRF2/HO-1 and NF-κB/NLRP3 Signaling Pathways. Journal of biochemical and molecular toxicology · 21 Jul 2026 PMID 42478942
- Rosmarinic acid in Suhuang antitussive capsule alleviates cough variant asthma by targeting EGFR. Journal of ethnopharmacology · 3 Jun 2026 PMID 42235719
Others — Formulated Combination Therapies (5)
- Disarming the Heat-Shock Response: Rosmarinic Acid Potentiates Mild Hyperthermia-Induced Apoptosis in A549 Non-Small Cell Lung Cancer Cells. Journal of biochemical and molecular toxicology · 24 Oct 2026 PMID 42921998
- Cascade-Therapeutic Nanozyme Hydrogel Mediates Hypoxia Alleviation and Angiogenesis Promotion To Accelerate Diabetic Wound Healing. ACS applied materials & interfaces · 13 Aug 2026 PMID 42587488
- QbD-engineered EGCG-rosmarinic acid cubosomal hydrogel for controlled skin delivery and antimelanoma efficacy. International journal of pharmaceutics · 25 Jul 2026 PMID 42501769
- A Brain-Targeted DNA Delivery Nanocarrier Modulator for Synergistic Therapy of Parkinson's Disease. ACS applied materials & interfaces · 2 Jul 2026 PMID 42390437
- Insulin complexation with curcumin derivative mitigates the protein amyloidosis and efficiently manages diabetes in Drosophila melanogaster. International journal of biological macromolecules · 22 Jun 2026 PMID 42331169
By study type
Human data, design not indexed (1)
- Disarming the Heat-Shock Response: Rosmarinic Acid Potentiates Mild Hyperthermia-Induced Apoptosis in A549 Non-Small Cell Lung Cancer Cells. Journal of biochemical and molecular toxicology · 24 Oct 2026 PMID 42921998
Preclinical: animal, cell and lab studies (10)
- A Novel Voltammetric Approach for the Rapid Quantification of Rosmarinic Acid in Origanum micranthum and Origanum minutiflorum. Chemistry & biodiversity · 1 Nov 2026 PMID 42967481
- Cascade-Therapeutic Nanozyme Hydrogel Mediates Hypoxia Alleviation and Angiogenesis Promotion To Accelerate Diabetic Wound Healing. ACS applied materials & interfaces · 13 Aug 2026 PMID 42587488
- QbD-engineered EGCG-rosmarinic acid cubosomal hydrogel for controlled skin delivery and antimelanoma efficacy. International journal of pharmaceutics · 25 Jul 2026 PMID 42501769
- Nano-Rosmarinic Acid Protects Against Chlorfenapyr-Induced Testicular Toxicity Through Modulation of NRF2/HO-1 and NF-κB/NLRP3 Signaling Pathways. Journal of biochemical and molecular toxicology · 21 Jul 2026 PMID 42478942
- A Brain-Targeted DNA Delivery Nanocarrier Modulator for Synergistic Therapy of Parkinson's Disease. ACS applied materials & interfaces · 2 Jul 2026 PMID 42390437
- Insulin complexation with curcumin derivative mitigates the protein amyloidosis and efficiently manages diabetes in Drosophila melanogaster. International journal of biological macromolecules · 22 Jun 2026 PMID 42331169
- Unlocking the Role of Chia (Salvia hispanica L.) Seed Phenolic Metabolites in Postprandial Glucose Modulation: in vitro, in vivo, and Antioxidant Evidence Supported by Molecular Docking. Plant foods for human nutrition (Dordrecht, Netherlands) · 18 Jun 2026 PMID 42313210
- Solvent-Dependent GC-MS and LC-MS/MS Phytochemical Profiling of Echium italicum L. Aerial Part Extracts and In Vitro Enzyme Inhibitory and DNA-Protective Effects. Biomedical chromatography : BMC · 11 Jun 2026 PMID 42274011
- Rosmarinic acid in Suhuang antitussive capsule alleviates cough variant asthma by targeting EGFR. Journal of ethnopharmacology · 3 Jun 2026 PMID 42235719
- Evaluation of the Phytochemical Composition, Antioxidant Activity, and Enzyme Inhibitory Potential of Salvia heldreichiana Within the Framework of Molecular Docking and CAVER Tunnel Analysis. ChemistryOpen · 1 Jun 2026 PMID 42220228
Written from 11 PubMed abstracts, each one listed by PMID above. Published: 2026-07-16. Last written: 2026-08-27 by GPT. Drafted by language models from published abstracts; not medical advice.